tiprankstipranks
Trending News
More News >
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Technical Analysis

Compare
353 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Lyra Therapeutics’s (LYRA) Moving Averages Convergence Divergence (MACD) indicator is 2.50, suggesting Lyra Therapeutics is a Buy.
Lyra Therapeutics’s (LYRA) 20-Day exponential moving average is 13.02, while Lyra Therapeutics’s (LYRA) share price is $11.34, making it a Sell.
Lyra Therapeutics’s (LYRA) 50-Day exponential moving average is 9.97, while Lyra Therapeutics’s (LYRA) share price is $11.34, making it a Buy.

Lyra Therapeutics (LYRA) Pivot Points

Jun 16, 2025, 01:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.08
10.30
11.07
12.29
13.06
14.28
15.06
Fibonacci
10.30
11.06
11.53
12.29
13.05
13.52
14.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lyra Therapeutics (LYRA) Moving Averages

Jun 16, 2025, 01:54 PM
Period
Simple
Exponential
MA5
14.12Sell
14.03Sell
MA10
19.09Sell
14.79Sell
MA20
11.96Sell
13.02Sell
MA50
7.83Buy
9.97Buy
MA100
8.45Buy
9.26Buy
MA200
10.03Buy
10.44Buy
Lyra Therapeutics’s (LYRA) 10-Day exponential moving average is 14.79, while Lyra Therapeutics’s (LYRA) share price is $11.34, making it a Sell.
Lyra Therapeutics’s (LYRA) 100-Day exponential moving average is 9.26, while Lyra Therapeutics’s (LYRA) share price is $11.34, making it a Buy.
Lyra Therapeutics’s (LYRA) stock price is $11.34 and Lyra Therapeutics’s (LYRA) 50-day simple moving average is 7.83, creating a Buy signal.
Lyra Therapeutics’s (LYRA) stock price is $11.34 and Lyra Therapeutics’s (LYRA) 100-day simple moving average is 8.45, creating a Buy signal.
Lyra Therapeutics’s (LYRA) stock price is $11.34 and Lyra Therapeutics’s (LYRA) 200-day simple moving average is 10.03, creating a Buy signal.

Lyra Therapeutics (LYRA) Technical Indicators

Jun 16, 2025, 01:54 PM
Name
Value
Implied Action
RSI (14)
48.99
Neutral
STOCH (9,6)
13.24
Buy
STOCHRSI (14)
24.99
Neutral
MACD (12,26)
2.50
Buy
ADX (14)
43.90
Neutral
Williams %R
-77.65
Buy
CCI (14)
-6.53
Neutral
ATR (14)
3.72
-
Ultimate Oscillator
29.50
Sell
ROC
147.06
Buy
Lyra Therapeutics’s (LYRA) Relative Strength Index (RSI) is 48.99, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Trend Strength Indicator (ADX) is 43.90, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Commodity Channel Index (CCI) is -6.53, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Price Rate of Change (ROC) is 147.06, creating a Buy signal.

FAQ

Is LYRA a Buy, Hold, or Sell?
Based on LYRA’s technical indicators, LYRA is a Hold.
    What is LYRA’s RSI (14)?
    LYRA’s RSI (14) is 48.99, which suggests LYRA is a Neutral.
      What is LYRA’s MACD?
      LYRA’s MACD is 2.50, which suggests LYRA is a Buy.
        What is LYRA’s 5-day moving average?
        LYRA’s 5-day moving average is 14.12, which suggests LYRA is a Sell.
          What is LYRA’s 20-day moving average?
          LYRA 20-day moving average is 11.96, which suggests LYRA is a Sell.
            What is LYRA’s 50-day moving average?
            LYRA’s 50-day moving average is 7.83, which suggests LYRA is a Buy.
              What is LYRA’s 200-day moving average?
              LYRA’s 200-day moving average is 10.03, which suggests LYRA is a Buy.
                What is LYRA’s Williams % R (14)?
                LYRA’s Williams % R (14) is -77.65, which suggests LYRA is a Buy.
                  What is LYRA’s CCI (14)?
                  LYRA’s CCI (14) is -6.53, which suggests LYRA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis